Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS students excel at FPI awards
2009-06-04

 
Top students Annemarie Trinder-Smith and Renier de Bruyn
Photo: Supplied


Two top achievers from the Centre for Financial Planning Law at the University of the Free State (UFS) were crowned nationally as top students by the Financial Planning Institute of Southern Africa (FPI) at a gala ceremony at Emperor’s Palace, Johannesburg, on Tuesday night.

Annemarie Trinder-Smith, a financial planner at Christo Saayman Financial Planners, was the best student in the Postgraduate Diploma in Financial Planning, while Renier de Bruyn, financial advisor at PSG Consult (George) was the best student in the Advanced Postgraduate Diploma in Financial Planning.

They were among 461 students of the Centre for Financial Planning Law at the University of the Free State (UFS) who earlier received their postgraduate diplomas at a ceremony that formed part of the annual FPI convention.

The Centre for Financial Planning Law, which was established in 2001, was the first and for five years the only academic centre in South Africa to present a Postgraduate Diploma in Financial Planning. Today the UFS is still the only institution to present this course through distance learning. The UFS is currently the only institution that offers the Advanced Postgraduate Diploma in Financial Planning.

At the diploma ceremony hosted earlier by the UFS, the following students were named as top achievers in various modules of the Postgraduate Diploma in Financial Planning:
• Mylie Archibald (Financial Planning Environment, Corporate Financial Planning)
• Shaun Matthews (Personal Financial Planning)
• Nicolette van der Linde (Financial Planning Case Study). She also received an FPI prize as top student.

In the Advanced Postgraduate Diploma in Financial Planning, the following students were named as top achievers in various modules by the UFS. They also received FPI prizes in these modules:
• Megan Joan Anika (Fund Governance and Maintenance)
• Sarah Lynn James (Fund Design and Financing)
• Melanie Louw (Personal Risk Management)
• Renier de Bruyn (Estate Planning, Asset Types and Investment Planning)
• Jan Willem Wessels (Principles of Portfolio Planning and Management)

According to Adv Wessel Oosthuizen, Director of the Centre for Financial Planning at the UFS, large companies, banks, insurers and investment managers enroll their staff for these qualifications.

“The two diplomas form the basis for financial planners, brokers, lawyers and bankers to be recognized as certified financial planners - the CFP® status - as well as obtaining membership of the FPI.”

“A qualified financial planner, especially a CFP®, is one of the most sought-after titles in the financial planning sector worldwide. With about 3 700 CFP’s, South Africa has the fifth highest number of certified financial planners in the world,” Adv Oosthuizen said.

Adv. Oosthuizen is well-known nationally and internationally for his contribution to the advancement of financial planning law and financial planning education.

He was recently invited by the Financial Planning Standards Board to serve on an international committee that will evaluate the quality of education in financial planning. He was also the chairperson of a working group that developed guidelines for a standardised international curriculum for financial planners.

Media Release:
Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt.stg@ufs.ac.za
04 June 2009
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept